Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane Effects on HSP70 in Cancer
NCT06626711Phase 1Active, not recruiting
- Sponsor
- Saint Petersburg State University
- Start
- Oct 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of propofol injection (veterinary) and sevoflurane in malignant neoplasm (2 arms), sponsored by Saint Petersburg State University. Primary endpoint: HSP70 expression in tumor cells in vitro at 24 hours. Started Oct 2024; status: active, not recruiting.
02
Drugs
propofol injection (veterinary)sevoflurane
03
Conditions
malignant neoplasm
Beyond the preview
Go deeper on NCT06626711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06626711.